Israeli generic drugmaker hires former Novartis executive Richard Francis to take over as new CEO starting January 1 Israeli generic drugmaker Teva Pharmaceuticals Industries said that its US affiliate has finalized the terms of a proposed nationwide settlement to resolve $4.25 billion in opioid-related claims. The settlement involves a flurry …
Read More »Teva finalizes terms of US opioid settlement worth $4.25 billion
